Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Breast cancer treated by copper-dithiocarbamate
May 10th, 2006
Breast cancer could be treated by copper-dithiocarbamate, Cu[DEDTC]2 . "Since diethyl dithiocarbamate (DEDTC) forms complexes with either zinc or copper, and 8-hydroxyquinoline (8-OHQ) also complexes with copper, we now compared the cytotoxic activity of Cu[DEDTC]2 , Zn[DEDTC]2 and Cu[8-OHQ]2 . This report shows that at nanomolar levels, only copper-[DEDTC]2 , suppresses proliferation and clonogenicity of SKBR3 human breast carcinoma, concurrently with induction of apoptosis-associated PARP fragmentation," scientists in Venezuela reported. "Susceptibility to these agents was paralleled by...
Source: Vaccine Weekly (2006-05-10)
|
